Andrew Liveris Lauds New Obama Focus On Economy


U.S. President Barack Obama's renewed focus on economic and regulatory issues shows a willingness to work with corporate America, the head of Dow Chemical said.
"The country's jobless recovery is not a good thing," Chief Executive Andrew Liveris said on Monday. "How can we make this a recovery that builds the new future? I think science-based regulations in our world are the only way forward."
Liveris has repeatedly made the case for a U.S.-based manufacturing renaissance, saying that the U.S. government and the private sector must work together to spur job growth.
Obama recently laid out his plan for an updated regulatory system in an opinion piece published in The Wall Street Journal. He is expected to further expound on the topic in his State of the Union speech before a joint session of Congress on Tuesday night.
"The president's op-ed was really progressive," said Liveris, who recently wrote the book "Make it in America: The Case for Reinventing the Economy," to outline his economic views. "A real blank-sheet-of-paper look at regulations across all industries is overdue. The president and his team are showing a great willingness to listen."
Liveris spoke at a news conference in Detroit where Midland, Mich.-based Dow Chemical announced a $10 million partnership with The Nature Conservancy.
Company
The Dow Chemical Company100 Larkin Center
48674 Midland
most read

Asahi Kasei Expands Planova Production with New Spinning Plant
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.

Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

MSD to Acquire Verona Pharma for $10 Billion
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.

Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.

VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.